In the first large trial of its kind, the anti-clotting medication rivaroxaban did not lower the risk of cognitive decline, stroke or transient ischemic attack (TIA) in people younger than age 65 who ...

A study of almost 13,000 adults with Type 2 diabetes and high systolic blood pressure assessed if a more intensive treatment ...

India led the world in diabetes cases in 2022, with over 212 million people affected and a staggering 62% left untreated, ...

Scouted selects products independently. If you purchase something from our posts, we may earn a small commission. The ...